XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Note 2 - Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2022
Notes Tables  
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]
  

March 31,

  

December 31,

 
  

2022

  

2021

 

Cash and cash equivalents

 $5,641  $7,504 

Restricted cash included in other assets

  152   475 

Total cash, cash equivalents, and restricted cash in the condensed consolidated statements of cash flows

 $5,793  $7,979 
Schedules of Concentration of Risk, by Product [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

  

2021

 

Avenova Spray

 $1,426  $1,575 

DERMAdoctor

  891    

NeutroPhase

  148    

Other products

  158   226 

Total product revenue, net

  2,623   1,801 

Other revenue, net

  6   6 

Total sales, net

 $2,629  $1,807 
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
  

March 31,

  

December 31,

 

Major distribution partner

 

2022

  

2021

 
Major U.S. Retailer  35%  33%

Avenova Spray Pharmacy Distributor B

  14

%

  11

%

Avenova Spray Pharmacy Distributor A

  13

%

  13

%

Schedule of Intangible Assets and Goodwill [Table Text Block]

Intangible Asset

 

Fair Value (in

thousands)

  

Useful Life

(in years)

 

Amortization

Method

Customer relationships

 $290   7 

Straight line

Trade secrets / product formulations

  2,890   9 

Straight line

Trade names

  2,080  

Indefinite

 N/A

Goodwill

  4,528  

Indefinite

 N/A
  $9,788      
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Three Months Ended March 31,

 

Numerator

 

2022

  

2021

 

Net loss

 $(111) $(1,518)
         

Denominator

        

Weighted average shares of common stock outstanding, basic and diluted

  50,088   41,782 

Net loss per share attributable to common stockholders, basic and diluted

 $0.00  $(0.04)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

  

2021

 

Stock options

  4,416   3,138 

Stock warrants

  44,582   7,082 
   48,998   10,220